Related Experiment Video
Updated: Jun 12, 2026

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation
Gabriel A Roybal1, Melissa S Jurica
1Department of Molecular, Cell and Developmental Biology and Center for Molecular Biology of RNA, University of California, Santa Cruz, CA, USA.
Abstract:
Pre-mRNA splicing is catalyzed by the large ribonucleoprotein spliceosome. Spliceosome assembly is a highly dynamic process in which the complex transitions through a number of intermediates. Recently, the potent anti-tumor compound Spliceostatin A (SSA) was shown to inhibit splicing and to interact with an essential component of the spliceosome, SF3b. However, it was unclear whether SSA directly impacts the spliceosome and, if so, by what mechanism, which limits interpretation of the drugs influence on splicing. Here, we report that SSA inhibits pre-mRNA splicing by interfering with the spliceosome subsequent to U2 snRNP addition. We demonstrate that SSA inhibition of spliceosome assembly requires ATP, key pre-mRNA splicing sequences and intact U1 and U2 snRNAs. Furthermore all five U snRNAs in addition to the SSA molecule associate with pre-mRNA during SSA inhibition. Kinetic analyses reveal that SSA impedes the A to B complex transition. Remarkably, our data imply that, in addition to its established function in early U2 snRNP recruitment, SF3b plays a role in later maturation of spliceosomes. This work establishes SSA as a powerful tool for dissecting the dynamics of spliceosomes in cells. In addition our data will inform the design of synthetic splicing modulator compounds for targeted anti-tumor treatment.
Insights
Spliceostatin A (SSA) inhibits pre-messenger RNA (pre-mRNA) splicing by disrupting spliceosome assembly after U2 small nuclear ribonucleoprotein (snRNP) addition. This reveals a new role for SF3b in spliceosome maturation, aiding anti-tumor drug development.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Pre-messenger RNA (pre-mRNA) splicing is a crucial cellular process.
- The spliceosome, a large ribonucleoprotein complex, catalyzes splicing through dynamic assembly intermediates.
- Spliceostatin A (SSA) is an anti-tumor compound known to inhibit splicing by interacting with SF3b.
Purpose of the Study:
- To elucidate the precise mechanism by which SSA inhibits pre-mRNA splicing.
- To determine if SSA directly impacts the spliceosome and its assembly dynamics.
- To explore the role of SF3b in spliceosome maturation.
Main Methods:
- Investigated SSA's effect on spliceosome assembly.
- Utilized kinetic analyses to study spliceosome complex transitions.
- Examined the association of U snRNAs and SSA with pre-mRNA during inhibition.
Main Results:
- SSA inhibits pre-mRNA splicing by interfering with spliceosome assembly post-U2 snRNP addition.
- SSA-induced inhibition requires ATP, splicing sequences, and intact U1/U2 snRNAs.
- Kinetic analysis showed SSA impedes the A to B spliceosome complex transition, involving all five U snRNAs.
Conclusions:
- SSA directly inhibits spliceosome assembly, specifically impeding the A to B complex transition.
- SF3b plays a role in later spliceosome maturation, beyond early U2 snRNP recruitment.
- SSA is a valuable tool for studying spliceosome dynamics and designing novel anti-tumor therapies.
Related Concept Videos
RNA Splicing
RNA Splicing
Pre-mRNA Processing: RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Chromatin Structure and RNA Splicing
The chromatin structure, especially...

